lovastatin has been researched along with Fatty Liver, Nonalcoholic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, L; Hao, S; Sun, H; Wang, Z; Yu, P; Zhang, M; Zhang, X | 1 |
| Hu, H; Jiang, SY; Li, JW; Li, YF; Meng, XY; Qi, W; Qu, YX; Rao, Y; Shao, YW; Song, BL; Tang, JJ; Wang, L; Xu, MQ; Yang, X; Yang, Z | 1 |
| Antonello, M; Brosolo, G; Catena, C; Da Porto, A; Donnini, D; Romanin, A; Sechi, LA; Soardo, G; Toritto, P; Vanin, F; Varisco, E | 1 |
| Feng, WW; Kuang, SY; Liu, TS; Ma, ZJ; Pang, JY; Tu, C; Wang, JB; Wang, YH; Xiao, XH; Zang, QC; Zhao, YL | 1 |
| Ahn, SC; Jang, HJ; Jeon, TI; Kim, KY; Osborne, TF; Park, KI; Seo, J; Seo, YK; Shin, IW; Suh, PG; Yang, YR | 1 |
5 other study(ies) available for lovastatin and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Synthesis of natural 3'-Prenylchalconaringenin and biological evaluation of ameliorating non-alcoholic fatty liver disease and metabolic syndrome.
Topics: 3T3-L1 Cells; AMP-Activated Protein Kinases; Animals; Chalcones; Chemistry Techniques, Synthetic; Hep G2 Cells; Humans; Metabolic Syndrome; Mice; Non-alcoholic Fatty Liver Disease; Signal Transduction; Stereoisomerism | 2020 |
Discovery of an insulin-induced gene binding compound that ameliorates nonalcoholic steatohepatitis by inhibiting sterol regulatory element-binding protein-mediated lipogenesis.
Topics: Animals; Cholesterol; Humans; Insulins; Islet Amyloid Polypeptide; Lipogenesis; Liver; Lovastatin; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Sterol Regulatory Element Binding Protein 1; Sterol Regulatory Element Binding Proteins; Triglycerides | 2022 |
Effects of Monacolin K in Nondiabetic Patients with NAFLD: A Pilot Study.
Topics: Glutathione Disulfide; Humans; Insulin Resistance; Liver; Lovastatin; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Pilot Projects; Prospective Studies | 2023 |
Natural products berberine and curcumin exhibited better ameliorative effects on rats with non-alcohol fatty liver disease than lovastatin.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Berberine; Biological Products; Blood Glucose; Body Weight; Curcumin; Gene Expression Regulation; Inflammation; Insulin; Intra-Abdominal Fat; Lipid Metabolism; Lipids; Lipopolysaccharides; Liver; Lovastatin; Male; Non-alcoholic Fatty Liver Disease; Organ Size; Oxidative Stress; Rats, Sprague-Dawley | 2018 |
SREBP-2/PNPLA8 axis improves non-alcoholic fatty liver disease through activation of autophagy.
Topics: Animals; Anticholesteremic Agents; Autophagosomes; Autophagy; Cells, Cultured; Diet, High-Fat; Disease Models, Animal; Drug Therapy, Combination; Ezetimibe; Group VI Phospholipases A2; Hepatocytes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Signal Transduction; Sterol Regulatory Element Binding Protein 2; Triglycerides | 2016 |